Insider · CIK 0001708681

Zago Wagner M.

Reports to the SEC for 1 company · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001708681

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-28	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+51K sh	—	—	85,000
2026-07-28	PRTAPROTHENA CORP PUBLIC LTD COD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−51K sh	$8.56	−$437K	34,000
2026-07-28	PRTAPROTHENA CORP PUBLIC LTD CO · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−51K sh	—	—	0
2026-03-03	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+190K sh	—	—	190,000
2025-07-28	PRTAPROTHENA CORP PUBLIC LTD COA Award	Chief Scientific Officer	AAward	+85K sh	—	—	85,000
2025-03-05	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+108K sh	—	—	107,500
2024-02-27	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+85K sh	—	—	85,000
2023-08-02	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,000 sh	$12.15	+$48.6K	4,000
2023-08-02	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−3,771 sh	$66.98	−$253K	229
2023-08-02	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−229 sh	$68.07	−$15.6K	0
2023-08-02	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,000 sh	—	—	58,000
2023-07-05	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,000 sh	$12.15	+$48.6K	4,000
2023-07-05	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−2,991 sh	$67.98	−$203K	1,009
2023-07-05	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−1,009 sh	$68.69	−$69.3K	0
2023-07-05	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,000 sh	—	—	62,000
2023-06-07	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+15K sh	$29.81	+$447K	15,000
2023-06-07	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,000 sh	$12.15	+$48.6K	19,000
2023-06-07	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−2,943 sh	$70.02	−$206K	16,057
2023-06-07	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−12K sh	$70.99	−$852K	4,053
2023-06-07	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−3,759 sh	$71.96	−$270K	294
2023-06-07	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−294 sh	$73.14	−$21.5K	0
2023-06-07	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−15K sh	—	—	0
2023-06-07	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,000 sh	—	—	66,000
2023-03-02	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+48K sh	—	—	48,000
2022-02-23	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+85K sh	—	—	85,000
2021-06-22	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+15K sh	$20.17	+$303K	15,000
2021-06-22	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+19K sh	$27.81	+$528K	34,000
2021-06-22	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+81.3K sh	$15.04	+$1.22M	115,250
2021-06-22	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−65.8K sh	$45.42	−$2.99M	49,410
2021-06-22	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−26.1K sh	$46.27	−$1.21M	23,304
2021-06-22	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−18.1K sh	$47.81	−$865K	5,203
2021-06-22	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−5,203 sh	$49.01	−$255K	0
2021-06-22	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−15K sh	—	—	0
2021-06-22	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−19K sh	—	—	0
2021-06-22	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−81.3K sh	—	—	68,750
2021-02-25	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+56K sh	—	—	56,000
2021-02-18	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+7,540 sh	$6.41	+$48.3K	7,540
2021-02-18	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−7,540 sh	$25.50	−$192K	0
2021-02-18	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−7,540 sh	—	—	0
2021-02-12	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+7,560 sh	$6.41	+$48.5K	7,560
2021-02-12	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−7,560 sh	$17.07	−$129K	0
2021-02-12	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+18.8K sh	$13.53	+$254K	18,750
2021-02-12	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Scientific Officer	SSale	−18.8K sh	$20.00	−$375K	0
2021-02-12	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−7,560 sh	—	—	7,540
2021-02-12	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−18.8K sh	—	—	31,250
2020-02-25	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+70K sh	—	—	70,000
2019-02-27	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+50K sh	—	—	50,000
2018-06-21	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+150K sh	—	—	150,000
2018-02-21	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+60K sh	—	—	60,000
2017-09-28	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+900 sh	$6.41	+$5,769	900

Recent filings

Accepted (ET)
Jul 304
Zago Wagner M.0000905148-26-003417
SEC(opens sec.gov)
Mar 54
Zago Wagner M.0000905148-26-001182
SEC(opens sec.gov)
Jul 304
Zago Wagner M.0000905148-25-002662
SEC(opens sec.gov)
Mar 74
Zago Wagner M.0000905148-25-000890
SEC(opens sec.gov)
Feb 294
Zago Wagner M.0000905148-24-000841
SEC(opens sec.gov)
Aug 24
Zago Wagner M.0001140361-23-037713
SEC(opens sec.gov)
Jul 54
Zago Wagner M.0001140361-23-033192
SEC(opens sec.gov)
Jun 74
Zago Wagner M.0001140361-23-028870
SEC(opens sec.gov)

Companies

PROTHENA CORP PUBLIC LTD COChief Scientific OfficerPRTA

Address

C/O PROTHENA BIOSCIENCES INC 1800 SIERRA POINT PARKWAY

BRISBANE, CA, 94005